TYPHIM Vi

Medicinal product

(Invented) name

TYPHIM Vi

Active substance (s)

Salmonella typhi (Ty2 padermės) polisacharidas

Strength

25 µg/dozėje

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J07AP03, Typhoid, purified polysaccharide antigen

Marketing authorisation holder

Sanofi Winthrop Industrie, Prancūzija

Date of authorisation

1995-02-15

Date of renewal

2008-05-12

Documents

1149 TYPHIM Vi II PL 2025 03 24.docx

1149 Pakuotės lapelis 2025 03 24.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Dozėje (0,5 ml) yra	0.5 ml
Salmonella typhi (Ty2 padermės) polisacharidas	25 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
9415	14069	1014069	užpildytas švirkštas	0,5 ml, N1		Receptinis	LT/1/95/1149/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2008-05-12	Perregistruotas
1995-02-15	Registruotas